I-Mab Total Current Liabilities

I-Mab (IMAB) currently reports a total current liabilities of $7.3M as of June 2025. That compares with $14M in the prior-year period — down 47.4% year over year. Use the charts on this page to explore I-Mab's total current liabilities history and peer comparisons.

I-Mab's total current liabilities decreased from $14M to $7.3M — a 47.4% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

I-Mab reported $7.3M in total current liabilities as of June 2025. That compares with $14M in the prior-year period — down 47.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $7.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for I-Mab, and consider following IMAB for alerts when major investors trade the stock.

I-Mab is classified in the Healthcare sector. On total current liabilities, it currently shows $7.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMAB with unrelated industries.